yes, things have been stagnant in the past, and i feel your frustration captain, however...OCAT just signed licensing deal with ALLELE for IPSC technology. I believe this is a big step forward for company in non core programs like platelets. OCAT is also much farther in current trials. They have 2 published papers and moving into phase 2 "PIVOTAL" trials shortly.
So yes, i believe big things are coming for OCAT in near future..